We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Chemours (CC) Up 30% in 3 Months: What's Driving the Rally?
Read MoreHide Full Article
The Chemours Company’s (CC - Free Report) shares have shot up 30.4% over the past three months. The company has also outperformed its industry’s rise of 12.9% to over the same time frame.
Chemours, a Zacks Rank #2 (Buy) stock, has a market cap of roughly $4.4 billion and average volume of shares traded in the last three months is around 1,064.7K.
Let’s delve deeper into the factors behind the stock’s price appreciation.
What’s Favoring CC?
Chemours is gaining from a recovery in demand from the coronavirus-induced slowdown and its cost-reduction measures. It delivered forecast-topping results in the third quarter on the back of demand recovery, cost-cutting actions and strong execution.
In its Fluoroproducts segment, the company is seeing improved customer demand for refrigerants, especially in the automotive sector on a rebound in automotive OEM production rates. It is also witnessing demand recovery in architectural coatings, laminates and plastics markets in its Titanium Technologies segment. The company is seeing a recovery across all markets and regions.
Chemours is also poised to benefit from increasing adoption of the Opteon platform and growing applications of fluoropolymers, especially in automotive, electronics and energy end-markets. The company is seeing higher demand for Opteon in mobile applications. It remains committed to drive Opteon adoption. It is ramping up production at the new low-cost Opteon Corpus Christi facility.
Moreover, the company stands to gain from its efforts to reduce costs. It is taking actions to cut costs by reducing overhead, discretionary spend and capital expenditure for 2020. These actions are helping it to generate strong cash flows. Chemours aims to cut costs by $160 million and capital expenditure by roughly $125 million in 2020. The company’s cost and operational improvement actions across its businesses are expected to support margins in 2020.
The company also has a strong liquidity position. It ended the third quarter with cash and cash equivalents of $956 million and total liquidity of $1.7 billion.
Earnings estimate revisions also have the greatest impact on stock prices. Over the past month, the Zacks Consensus Estimate for Chemours for the current year has increased around 15%. The consensus estimate for 2021 has also been revised 17.1% upward over the same time frame.
Other top-ranked stocks worth considering in the basic materials space include Bunge Limited (BG - Free Report) , Impala Platinum Holdings Limited (IMPUY - Free Report) and BHP Group (BHP - Free Report) .
Bunge has an expected earnings growth rate of 43% for the current year. The company’s shares have gained around 15% in the past year. It currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Impala Platinum has an expected earnings growth rate of 131.7% for the current fiscal. The company’s shares have rallied around 29% in the past year. It currently carries a Zacks Rank #2.
BHP Group has a projected earnings growth rate of 32.4% for the current fiscal year. The company’s shares have gained around 18% in a year. It currently carries a Zacks Rank #2.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.4% per year.
These 7 were selected because of their superior potential for immediate breakout.
Image: Bigstock
Chemours (CC) Up 30% in 3 Months: What's Driving the Rally?
The Chemours Company’s (CC - Free Report) shares have shot up 30.4% over the past three months. The company has also outperformed its industry’s rise of 12.9% to over the same time frame.
Chemours, a Zacks Rank #2 (Buy) stock, has a market cap of roughly $4.4 billion and average volume of shares traded in the last three months is around 1,064.7K.
Let’s delve deeper into the factors behind the stock’s price appreciation.
What’s Favoring CC?
Chemours is gaining from a recovery in demand from the coronavirus-induced slowdown and its cost-reduction measures. It delivered forecast-topping results in the third quarter on the back of demand recovery, cost-cutting actions and strong execution.
In its Fluoroproducts segment, the company is seeing improved customer demand for refrigerants, especially in the automotive sector on a rebound in automotive OEM production rates. It is also witnessing demand recovery in architectural coatings, laminates and plastics markets in its Titanium Technologies segment. The company is seeing a recovery across all markets and regions.
Chemours is also poised to benefit from increasing adoption of the Opteon platform and growing applications of fluoropolymers, especially in automotive, electronics and energy end-markets. The company is seeing higher demand for Opteon in mobile applications. It remains committed to drive Opteon adoption. It is ramping up production at the new low-cost Opteon Corpus Christi facility.
Moreover, the company stands to gain from its efforts to reduce costs. It is taking actions to cut costs by reducing overhead, discretionary spend and capital expenditure for 2020. These actions are helping it to generate strong cash flows. Chemours aims to cut costs by $160 million and capital expenditure by roughly $125 million in 2020. The company’s cost and operational improvement actions across its businesses are expected to support margins in 2020.
The company also has a strong liquidity position. It ended the third quarter with cash and cash equivalents of $956 million and total liquidity of $1.7 billion.
Earnings estimate revisions also have the greatest impact on stock prices. Over the past month, the Zacks Consensus Estimate for Chemours for the current year has increased around 15%. The consensus estimate for 2021 has also been revised 17.1% upward over the same time frame.
The Chemours Company Price and Consensus
The Chemours Company price-consensus-chart | The Chemours Company Quote
Stocks to Consider
Other top-ranked stocks worth considering in the basic materials space include Bunge Limited (BG - Free Report) , Impala Platinum Holdings Limited (IMPUY - Free Report) and BHP Group (BHP - Free Report) .
Bunge has an expected earnings growth rate of 43% for the current year. The company’s shares have gained around 15% in the past year. It currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Impala Platinum has an expected earnings growth rate of 131.7% for the current fiscal. The company’s shares have rallied around 29% in the past year. It currently carries a Zacks Rank #2.
BHP Group has a projected earnings growth rate of 32.4% for the current fiscal year. The company’s shares have gained around 18% in a year. It currently carries a Zacks Rank #2.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.4% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>